Rouven Bergmann Sells 3,000 Shares of Medidata Solutions Inc (MDSO) Stock

Medidata Solutions Inc (NASDAQ:MDSO) CFO Rouven Bergmann sold 3,000 shares of the stock in a transaction that occurred on Wednesday, January 24th. The shares were sold at an average price of $70.00, for a total transaction of $210,000.00. Following the transaction, the chief financial officer now directly owns 84,775 shares of the company’s stock, valued at $5,934,250. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Rouven Bergmann also recently made the following trade(s):

  • On Friday, January 19th, Rouven Bergmann sold 2,000 shares of Medidata Solutions stock. The shares were sold at an average price of $66.46, for a total transaction of $132,920.00.
  • On Tuesday, December 19th, Rouven Bergmann sold 2,000 shares of Medidata Solutions stock. The shares were sold at an average price of $65.95, for a total transaction of $131,900.00.
  • On Thursday, November 30th, Rouven Bergmann sold 2,000 shares of Medidata Solutions stock. The stock was sold at an average price of $65.40, for a total transaction of $130,800.00.

Shares of Medidata Solutions Inc (NASDAQ MDSO) opened at $62.48 on Tuesday. Medidata Solutions Inc has a 12-month low of $54.36 and a 12-month high of $85.92. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.50 and a quick ratio of 3.37. The company has a market cap of $3,807.70, a PE ratio of 84.43, a PEG ratio of 3.49 and a beta of 1.58.

Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Thursday, February 8th. The company reported $0.41 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.10. Medidata Solutions had a net margin of 8.14% and a return on equity of 11.59%. The firm had revenue of $141.20 million during the quarter, compared to analysts’ expectations of $140.65 million. During the same period last year, the company posted $0.33 EPS. The company’s quarterly revenue was up 13.4% compared to the same quarter last year. research analysts predict that Medidata Solutions Inc will post 0.9 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Champlain Investment Partners LLC lifted its position in Medidata Solutions by 9.6% during the 4th quarter. Champlain Investment Partners LLC now owns 1,856,985 shares of the company’s stock valued at $117,677,000 after acquiring an additional 163,045 shares during the period. State Street Corp lifted its position in Medidata Solutions by 27.7% during the 2nd quarter. State Street Corp now owns 1,828,913 shares of the company’s stock valued at $143,022,000 after acquiring an additional 396,793 shares during the period. American Century Companies Inc. lifted its position in Medidata Solutions by 21.3% during the 4th quarter. American Century Companies Inc. now owns 1,439,710 shares of the company’s stock valued at $91,234,000 after acquiring an additional 252,867 shares during the period. Global Thematic Partners LLC lifted its position in Medidata Solutions by 37.3% during the 4th quarter. Global Thematic Partners LLC now owns 1,429,138 shares of the company’s stock valued at $90,564,000 after acquiring an additional 388,608 shares during the period. Finally, Canada Pension Plan Investment Board lifted its position in Medidata Solutions by 2,994.6% during the 3rd quarter. Canada Pension Plan Investment Board now owns 1,151,200 shares of the company’s stock valued at $89,863,000 after acquiring an additional 1,114,000 shares during the period. 97.52% of the stock is owned by institutional investors.

Several research firms have issued reports on MDSO. SunTrust Banks reiterated a “buy” rating and issued a $92.00 target price on shares of Medidata Solutions in a research note on Friday, October 27th. Wells Fargo & Co lowered their price objective on shares of Medidata Solutions from $83.00 to $80.00 and set a “market perform” rating on the stock in a research report on Friday, October 27th. Dougherty & Co assumed coverage on shares of Medidata Solutions in a research report on Thursday, November 2nd. They set a “neutral” rating on the stock. Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research report on Thursday, November 2nd. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $80.00 target price on shares of Medidata Solutions in a report on Friday, October 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company. Medidata Solutions presently has a consensus rating of “Buy” and an average target price of $83.00.

ILLEGAL ACTIVITY NOTICE: “Rouven Bergmann Sells 3,000 Shares of Medidata Solutions Inc (MDSO) Stock” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/02/13/insider-selling-medidata-solutions-inc-mdso-cfo-sells-210000-00-in-stock.html.

About Medidata Solutions

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Insider Buying and Selling by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply